These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 2658462)

  • 21. Topical retinoid therapy for squamous metaplasia of various ocular surface disorders. A multicenter, placebo-controlled double-masked study.
    Soong HK; Martin NF; Wagoner MD; Alfonso E; Mandelbaum SH; Laibson PR; Smith RE; Udell I
    Ophthalmology; 1988 Oct; 95(10):1442-6. PubMed ID: 3067180
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spontaneous canine keratoconjunctivitis sicca. A useful model for human keratoconjunctivitis sicca: treatment with cyclosporine eye drops.
    Kaswan RL; Salisbury MA; Ward DA
    Arch Ophthalmol; 1989 Aug; 107(8):1210-6. PubMed ID: 2757551
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical evaluation of 1% cyclosporine for topical treatment of keratoconjunctivitis sicca in dogs.
    Olivero DK; Davidson MG; English RV; Nasisse MP; Jamieson VE; Gerig TM
    J Am Vet Med Assoc; 1991 Oct; 199(8):1039-42. PubMed ID: 1748606
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tear osmolarity and ocular surface disease in keratoconjunctivitis sicca.
    Gilbard JP; Farris RL
    Arch Ophthalmol; 1979 Sep; 97(9):1642-6. PubMed ID: 475632
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pilot trial of cyclosporine 1% ophthalmic ointment in the treatment of keratoconjunctivitis sicca.
    Laibovitz RA; Solch S; Andriano K; O'Connell M; Silverman MH
    Cornea; 1993 Jul; 12(4):315-23. PubMed ID: 8339560
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The clinical use of viscoelastic artificial tears and sodium chloride in dry-eye syndrome.
    Nepp J; Schauersberger J; Schild G; Jandrasits K; Haslinger-Akramian J; Derbolav A; Wedrich A
    Biomaterials; 2001 Dec; 22(24):3305-10. PubMed ID: 11700802
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hydroxypropylmethyl-containing eyedrops in the treatment of sicca syndrome].
    Török M
    Klin Monbl Augenheilkd; 1985 Jul; 187(1):60-2. PubMed ID: 4068574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Eledoisin eyedrops in the therapy of keratoconjunctivitis sicca].
    Spinelli D; Trabucchi P; Formenti F
    Ophtalmologie; 1988; 2(2):145-7. PubMed ID: 3247153
    [No Abstract]   [Full Text] [Related]  

  • 29. Precorneal residence times of sodium hyaluronate solutions studied by quantitative gamma scintigraphy.
    Snibson GR; Greaves JL; Soper ND; Prydal JI; Wilson CG; Bron AJ
    Eye (Lond); 1990; 4 ( Pt 4)():594-602. PubMed ID: 2226990
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Topical cyclosporine A 0.05% in the treatment of keratoconjunctivitis sicca].
    Schrell C; Cursiefen C; Kruse F; Jacobi C
    Klin Monbl Augenheilkd; 2012 May; 229(5):548-53. PubMed ID: 22189827
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The clinical use of sodium hyaluronate eyedrops as a substitute for tears].
    He Z; Han S; Zhen Z; Ding X; Liang S
    Yan Ke Xue Bao; 1990 Dec; 6(3-4):111-2. PubMed ID: 2289573
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment of a severe course of keratoconjunctivitis sicca with eledoisin].
    Jaeger W
    Klin Monbl Augenheilkd; 1988 Feb; 192(2):163-6. PubMed ID: 3283426
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unpreserved carboxymethylcellulose artificial tears evaluated in patients with keratoconjunctivitis sicca.
    Grene RB; Lankston P; Mordaunt J; Harrold M; Gwon A; Jones R
    Cornea; 1992 Jul; 11(4):294-301. PubMed ID: 1424648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An electrolyte-based solution that increases corneal glycogen and conjunctival goblet-cell density in a rabbit model for keratoconjunctivitis sicca.
    Gilbard JP; Rossi SR
    Ophthalmology; 1992 Apr; 99(4):600-4. PubMed ID: 1584579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparative clinical study of tear substitutes in normal subjects and in patients with keratoconjunctivitis sicca.
    Marner K; Prause JU
    Acta Ophthalmol (Copenh); 1984 Feb; 62(1):91-5. PubMed ID: 6202090
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of sodium hyaluronate ophthalmic solution on peripheral staining of rigid contact lens wearers.
    Itoi M; Kim O; Kimura T; Kanai A; Momose T; Kanki K; Yamaguchi T; Ueno Y; Kurokawa M; Komemushi S
    CLAO J; 1995 Oct; 21(4):261-4. PubMed ID: 8565197
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Slow-release artificial tear inserts in the treatment of dry eyes in patients with rheumatoid arthritis.
    Hill JC
    Br J Ophthalmol; 1989 Feb; 73(2):151-4. PubMed ID: 2649149
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sodium hyaluronate eyedrops in the treatment of dry eyes.
    Shimmura S; Ono M; Shinozaki K; Toda I; Takamura E; Mashima Y; Tsubota K
    Br J Ophthalmol; 1995 Nov; 79(11):1007-11. PubMed ID: 8534643
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immediate Effect of 3% Diquafosol Ophthalmic Solution on Tear MUC5AC Concentration and Corneal Wetting Ability in Normal and Experimental Keratoconjunctivitis Sicca Rat Models.
    Choi KE; Song JS; Kang B; Eom Y; Kim HM
    Curr Eye Res; 2017 May; 42(5):666-671. PubMed ID: 27791390
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Piroxicam eyedrops in keratoconjunctivitis sicca. A new therapeutic perspective].
    Bragliani G; Franco F; Marescotti A; Gaiba G
    Ophtalmologie; 1988 Oct; 2(4):359-62. PubMed ID: 3247209
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.